BPC 157 and blood vessels

Current Pharmaceutical Design

Volumn 20, Issue 7, 2014, Pages 1121-1125

  Seiwerth, Sven ^a,b   Brcic, Luka ^a,b   Vuletic, Lovorka Batelja ^a,b   Kolenc, Danijela ^a,b   Aralica, Gorana ^a,b   Misic, Marija ^a,b   Zenko, Anita ^a,b   Drmic, Domagoj ^a,b   Rucman, Rudolf ^a,b   Sikiric, Predrag ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Adults; Angiogenesis; Arteriogenesis; Blood vessel leakage; Blood vessel obstruction; Edema; Embryonic fetal; Exudate; Healing tumors; Hypoxia occlusion induced; Minimal vessel wall damage induced; Pressure induced; Primary development; Secondary; Thrombosis; Vasculogenesis; Vessel wall damage; Vessel wall damage induced

Indexed keywords

GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; PEPTIDE FRAGMENT; PROTEIN;

ANGIOGENESIS; ANIMAL; BLOOD VESSEL; CHEMICALLY INDUCED; DRUG EFFECTS; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; WOUND HEALING;

ANIMALS; BLOOD VESSELS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PROTEINS; WOUND HEALING;

EID: 84895162147     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990421     Document Type: Review

References (58)

1. Jin SW, Patterson C. The opening act: vasculogenesis and the origins of circulation. Arterioscler Thromb Vasc Biol 2009; 2: 623-9.
2. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003; 47: 149-61.
3. Chen CH, Chang LT, Tung WC, et al. Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients. J Biomed Sci 2012; 19: 66.
4. Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2012; 2: a006692.
5. Han M, Yang X, Taylor G, Burdsal CA, Anderson RA, Muneoka K. Limb regeneration in higher vertebrates: developing a roadmap. Anat Rec B New Anat 2005; 287: 14-24.
6. San Miguel-Ruiz JE, García-Arrarás JE. Common cellular events occur during wound healing and organ regeneration in the sea cucumber Holothuria glaberrima. BMC Dev Biol 2007; 7: 115.
7. Järvinen PM, Laiho M. LIM-domain proteins in transforming growth factor -induced epithelial-to-mesenchymal transition and myofibroblast differentiation. Cell Signal 2012; 24: 819-25.
8. Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999; 65: 22-6.
9. Ahn GO, Brown JM. Role of progenitors and other bone marrowderived cells in the development of the tumor vasculature. Angiogenesis 2009; 12: 159-64.
10. Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN. Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 2004; 164: 1887-92.
11. Sikiric P, Seiwerth S, Rucman R, et al. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem 2012; 19: 126-32.
12. Seiwerth S, Sikiric P, Grabarevic Z, et al. BPC 157's effect on healing. J Physiol Paris 1997; 91: 173-8.
13. Mikus D, Sikiric P, Seiwerth S, et al. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns 2001; 27: 817-27.
14. Sikiric P, Seiwerth S, Mise S, et al. Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice. Burns 2003; 29: 323-34.
15. Klicek R, Sever M, Radic B, et al. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. J Pharmacol Sci 2008; 108: 7-17.
16. Vuksic T, Zoricic I, Brcic L, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat. Surg Today 2007; 37(9): 768-77.
17. Sever M, Klicek R, Radic B, et al. Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats. Dig Dis Sci 2009; 54(10): 2070-83.
18. Cesarec V, Becejac T, Misic M, et al. Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy. Eur J Pharmacol 2013; 701: 203-12.
19. Staresinic M, Sebecic B, Jadrijevic S, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orth Res 2003; 21: 976-83.
20. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol 2011; 110: 774-80.
21. Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon to bone healing and opposed corticosteroid aggravation. J Orthop Res 2006; 24: 982-9.
22. Krivic A, Majerovic M, Jelic I, Seiwerth S, Sikiric P. Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Inflamm Res 2008; 57: 205-10.
23. Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res 2010;28:1155-61.
24. Staresinic M, Petrovic I, Novinscak T, Jukic I, Pevec D, Suknaic S, et al. Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157. J Orthopaed Res 2006;24:1109-17.
25. Novinscak T, Brcic L, Staresinic M, et al. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. Surg Today 2008; 38: 716-25.
26. Pevec D, Novinscak T, Brcic L, et al. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit 2010; 16: BR81-8.
27. Sebeci B, Nikoli V, Sikiri P, et al. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone 1999; 24: 195-202.
28. Keremi B, Lohinai Z, Komora P, et al. Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. J Physiol Pharmacol 2009; 60: 115-22.
29. Gamulin O, Serec K, Bilic V, et al. Monitoring the healing process of rat bones using Raman spectroscopy. J Mol Struct 2013 (in press).
30. Sikiric P, Seiwerth S, Grabarevic Z, et al. The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sci 1994; 54: PL63-8.
31. Hrelec M, Klicek R, Brcic L, et al. Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy. J Physiol Pharmacol 2009; 60: 161-5.
32. Sikiri P, Seiwerth S, Grabarevi Z, et al. The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol 1997; 332: 23-33.
33. Turkovic B, Sikiric P, Seiwerth S, et al. Stable gastric pentadecapeptide BPC 157 studied for inflammatory bowel disease (PLD-116, PL14736, Pliva) induces nitric oxide synthesis. Gastroenterology 2004; 126: 287.
34. Lovric-Bencic M, Sikiric P, Hanzevacki JS, et al. Doxorubicinecongestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse. J Pharmacol Sci 2004; 95: 19-26.
35. Grabarevic Z, Tisljar M, Artukovic B, Bratulic M, Dzaja P, Seiwerth S, et al.The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J Physiol Paris 1997;91:139-49.
36. Balenovic D, Bencic ML, Udovicic M, et al. Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. Regul Pept 2009; 156: 83-9.
37. Balenovic D, Barisic I, Prkacin I, et al. Mortal furosemidehypokalemia-disturbances in rats NO-system related. Shorten survival by L-NAME. Therapy benefit with BPC 157 more than with L-arginine. J Clin Exp Cardiolog 2012; 3: 201.
38. Barisic I, Balenovic D, Klicek R, et al. Mortal hyperkalemia disturbance in rats is NO-system related. The life saving effect of pentadecapeptide BPC 157. Regul Pept 2013;181:50-66.
39. Boban-Blagaic A, Blagaic V, Romic Z, et al. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-L-arginine methyl ester and L-arginine. Med Sci Monit 2006; 12: 36-45.
40. Veljaca M, Krnic Z, Brajsa K, et al. The development of PL 14736 for treatment of in ammatory bowel disease. IUPHAR-GI Section Symposium, Honolulu, Hawaii. 2002; 13-15 July, 0-32.
41. Veljaca M, Pavic Sladoljev D, Mildner B, et al. Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers. Gut 51 2003; Suppl III, A309.
42. Batelja L, Vuletic B, Brcic L, et al. RNA VEGF-A expression and VEGF-A protein in skin wound healing. Virchows Arch 2007; 451: 535.
43. Batelja L, Vuleti B, Kapitanovi S, et al. Expression of VEGF-A in wound healing by second intention and its relation to cellular parameters. Virchows Arch 2008; Suppl 1: S103.
44. Tkalcevic VI, Cuzic S, Brajsa K, Mildner B, Bokulic A, Situm K, et al. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur J Pharmacol 2007;570:212-21.
45. Enholm B, Paavonen K, Ristimäki A, et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997; 14: 2475-83.
46. Kumbrink J, Gerlinger M, Johnson JP. Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop. J Biol Chem 2005; 280: 42785-93.
47. Lucerna M, Mechtcheriakova D, Kadl A, et al. NAB2, a corepres- sor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. J Biol Chem 2003; 278: 11433-40.
48. Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angio- genesis in muscle and tendon healing. J Physiol Pharmacol 2009; 60: 191-6.
49. Enciso JM, Konecny CM, Karpen HE, Hirschi KK. Endothelial cell migration during murine yolk sac vascular remodeling occurs by means of a Rac1 and FAK activation pathway in vivo. Dev Dyn 2010; 239: 2570-83.
50. Sandor Zs, Vincze A, Jadus MR, Dohoczky Cs, Erceg D, Szabo S. The protective effect of newly isolated peptide PL-10 in the io- doacetamide colitis model in rats. Gastroenterology 1997; 112: A400.
51. Khomenko T, Szabo S, Deng XM, Sandor Z, Gombos Z, Yoshida M. Cell proliferation, transcription factor Egr-1 and growth factors in experimental ulcerative colitis after treatment with PL 14736: In vitro and in vivo studies. Gastroenterology 2003; 24: A493.
52. Tykocki NR, Watts SW. The interdependence of endothelin-1 and calcium: a review. Clin Sci (Lond) 2010; 119: 361-72.
53. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des 2013
54. Stupnisek M, Franjic S, Drmic D, et al. Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin. Thromb Res 2012; 129: 652-9.
55. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
56. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
57. Sikiric P, Seiwerth S, Brcic L, et al. Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. Curr Pharm Des 2010; 16: 1224-34.
58. Chen XL, Nam JO, Jean C, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22: 146-57.